Acquisition valued at $2.9 billion.
Soleno Therapeutics has an approved medicine for a rare disease.
The rare disease causes insatiable hunger.
Acquisition valued at $2.9 billion.
Soleno Therapeutics has an approved medicine for a rare disease.
The rare disease causes insatiable hunger.